Labcorp (NYSE:LH – Get Free Report) and AirSculpt Technologies (NASDAQ:AIRS – Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, analyst recommendations, dividends, earnings and risk.
Risk and Volatility
Labcorp has a beta of 0.88, suggesting that its stock price is 12% less volatile than the S&P 500. Comparatively, AirSculpt Technologies has a beta of 2.25, suggesting that its stock price is 125% more volatile than the S&P 500.
Institutional & Insider Ownership
95.9% of Labcorp shares are held by institutional investors. Comparatively, 91.5% of AirSculpt Technologies shares are held by institutional investors. 0.8% of Labcorp shares are held by insiders. Comparatively, 44.6% of AirSculpt Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Labcorp | $13.95 billion | 1.86 | $876.50 million | $12.09 | 26.40 |
| AirSculpt Technologies | $150.72 million | 1.10 | -$11.67 million | ($0.18) | -12.81 |
Labcorp has higher revenue and earnings than AirSculpt Technologies. AirSculpt Technologies is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a breakdown of recent ratings and price targets for Labcorp and AirSculpt Technologies, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Labcorp | 0 | 3 | 9 | 0 | 2.75 |
| AirSculpt Technologies | 1 | 1 | 0 | 0 | 1.50 |
Labcorp currently has a consensus price target of $336.36, indicating a potential upside of 5.37%. AirSculpt Technologies has a consensus price target of $4.50, indicating a potential upside of 95.23%. Given AirSculpt Technologies’ higher probable upside, analysts clearly believe AirSculpt Technologies is more favorable than Labcorp.
Profitability
This table compares Labcorp and AirSculpt Technologies’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Labcorp | 6.99% | 16.74% | 7.81% |
| AirSculpt Technologies | -7.79% | -5.83% | -2.88% |
Summary
Labcorp beats AirSculpt Technologies on 11 of the 14 factors compared between the two stocks.
About Labcorp
Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.
About AirSculpt Technologies
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that use the patient’s own fat cells to enhance the breasts, buttocks, hips, or other areas. The company’s body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. It operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.
Receive News & Ratings for Labcorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Labcorp and related companies with MarketBeat.com's FREE daily email newsletter.
